Table 3. MCID patient-referencing results.
| Instrument |
No/hardly any improvement (GRC −1, 0 or +1) N=98 |
Minimal improvement (GRC +2 or +3) N=196 |
Moderate improvement (GRC +4 or +5) N=123 |
Major improvement (GRC +6 or +7) N=25 |
||||
|---|---|---|---|---|---|---|---|---|
| Δa | 95% CIb | Δa | 95% CIb | Δa | 95% CIb | Δa | 95% CIb | |
|
CCQ | ||||||||
| Symptoms | −0.32 | −0.54 to −0.10 | −0.55 | −0.70 to −0.40 | −0.76 | −0.96 to −0.56 | −1.48 | −1.97 to −0.99 |
| Functional | −0.27 | −0.47 to −0.07 | −0.55 | −0.68 to −0.43 | −0.78 | −0.98 to −0.58 | −0.97 | −1.31 to −0.63 |
| Mental | −0.53 | −0.84 to −0.22 | −0.58 | −0.78 to −0.38 | −0.67 | −0.94 to −0.39 | −1.34 | −1.84 to −0.84 |
| Total | −0.34 | −0.52 to −0.15 | −0.56 | −0.68 to −0.44 | −0.75 | −0.92 to −0.58 | −1.25 | −1.54 to −0.96 |
| CAT | ||||||||
| Total | −2.05 | −3.13 to −0.98 | −3.12 | −3.86 to −2.37 | −3.67 | −4.70 to −2.67 | −6.44 | −8.99 to −3.89 |
| SGRQ | ||||||||
| Symptoms | −7.03 | −10.86 to −3.19 | −13.12 | −16.05 to −10.19 | −19.91 | −23.92 to −15.90 | −30.62 | −38.40 to −22.84 |
| Activities | −3.03 | −5.28 to −0.78 | −5.9 | −7.88 to −4.08 | −10.33 | −12.78 to −7.87 | −12.66 | −18.69 to −6.62 |
| Impact | −6.72 | −9.57 to −3.86 | −8.24 | −10.14 to −6.33 | −10.32 | −12.77 to −7.87 | −17.90 | −23.64 to −12.16 |
| Total | −5.57 | −7.79 to −3.35 | −8.40 | −10.07 to −6.73 | −11.83 | −14.00 to −9.66 | −18.50 | −22.81 to −14.18 |
Abbreviations: CAT, COPD assessment test; CCQ, Clinical COPD Questionnaire; CI, confidence interval; GRC, global rating of change; MCID, minimal clinically important difference; SGRQ, St. George’s Respiratory Questionnaire; Δ, change score; 95% CI, 95% confidence interval.
Data were reported as mean change scores. Negative change represents improvement for all instruments.
Paired t-tests were applied to normally distributed variables, and Wilcoxon signed-rank tests were used for not normally distributed data. Data were reported as 95% CI. All change scores were significant with P-value <0.05.